|
Volumn 21, Issue 14, 2011, Pages 4292-4295
|
New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)
|
Author keywords
Adjuvanticity; HBV; MDP mimics; Solid phase synthesis
|
Indexed keywords
CARBOHYDRATE;
EPITOPE;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B VACCINE;
ISOLEUCYLPROLYLGLUTAMINYLSERYLLEUCYLASPARTYLSERYLTRYPTOPHANYLTRYPTOPHANYLTHREONYLSERYL LEUCINE;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MURAMYL DIPEPTIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIGENICITY;
ARTICLE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG POTENTIATION;
DRUG SCREENING;
EX VIVO STUDY;
IMMUNOREACTIVITY;
MOUSE;
NONHUMAN;
SOLID PHASE SYNTHESIS;
ACETYLMURAMYL-ALANYL-ISOGLUTAMINE;
ADJUVANTS, IMMUNOLOGIC;
AMINO ACID SEQUENCE;
ANIMALS;
CARBOHYDRATES;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VACCINES;
MICE;
MICE, INBRED BALB C;
RECOMBINANT PROTEINS;
STRUCTURE-ACTIVITY RELATIONSHIP;
HEPATITIS B VIRUS;
MUS;
|
EID: 79959862307
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.05.056 Document Type: Article |
Times cited : (14)
|
References (20)
|